{
  "doc_id": "06622a35a6789bcf22cd7b982177703c9464bb7fd079b9ba8dc15420ad133e7c",
  "chunk_entities": [
    {
      "chunk_id": "94365409e9610e8e08fbe59c0b9a7e96",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "Addictive Disorders",
          "context": "Neurobiology of Addictive Disorders"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Drug Abuse",
          "context": "National Institute on Drug Abuse"
        }
      ]
    },
    {
      "chunk_id": "7ec3c94dfad1616c3e5245ed2a978d86",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "Drug addiction",
          "context": "Drug addiction is a chronically relapsing disorder"
        },
        {
          "entity_type": "Effect",
          "entity_name": "compulsion",
          "context": "compulsion to seek and take the drug"
        },
        {
          "entity_type": "Effect",
          "entity_name": "loss of control",
          "context": "loss of control in limiting intake"
        },
        {
          "entity_type": "Effect",
          "entity_name": "negative emotional state",
          "context": "emergence of a negative emotional state"
        },
        {
          "entity_type": "Effect",
          "entity_name": "dysphoria",
          "context": "eg, dysphoria, anxiety, irritability"
        },
        {
          "entity_type": "Effect",
          "entity_name": "anxiety",
          "context": "eg, dysphoria, anxiety, irritability"
        },
        {
          "entity_type": "Effect",
          "entity_name": "irritability",
          "context": "eg, dysphoria, anxiety, irritability"
        },
        {
          "entity_type": "Disease",
          "entity_name": "motivational withdrawal syndrome",
          "context": "reflecting a motivational withdrawal syndrome"
        },
        {
          "entity_type": "Effect",
          "entity_name": "impulsivity",
          "context": "elements of both impulsivity and compulsivity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "compulsivity",
          "context": "elements of both impulsivity and compulsivity"
        },
        {
          "entity_type": "Disease",
          "entity_name": "addiction cycle",
          "context": "a composite addiction cycle"
        },
        {
          "entity_type": "Effect",
          "entity_name": "binge/intoxication",
          "context": "three stages: 'binge/intoxication'"
        },
        {
          "entity_type": "Effect",
          "entity_name": "withdrawal/negative affect",
          "context": "'withdrawal/negative affect'"
        },
        {
          "entity_type": "Effect",
          "entity_name": "preoccupation/anticipation",
          "context": "'preoccupation/anticipation'"
        },
        {
          "entity_type": "Effect",
          "entity_name": "craving",
          "context": "(craving)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "disrupted inhibitory control",
          "context": "in disrupted inhibitory control"
        },
        {
          "entity_type": "Disease",
          "entity_name": "addiction",
          "context": "The transition to addiction"
        },
        {
          "entity_type": "Effect",
          "entity_name": "neuroplasticity",
          "context": "involves neuroplasticity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "mesolimbic dopamine system"
        },
        {
          "entity_type": "Effect",
          "entity_name": "neuroadaptations",
          "context": "a cascade of neuroadaptations"
        },
        {
          "entity_type": "Effect",
          "entity_name": "dysregulation",
          "context": "eventually dysregulation of the prefrontal cortex"
        },
        {
          "entity_type": "Disease",
          "entity_name": "addiction syndrome",
          "context": "the addiction syndrome"
        }
      ]
    },
    {
      "chunk_id": "ab5adff416c8d1eb824bdeb2aa3eae9f",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "substance dependence",
          "context": "going on to substance dependence on illicit drugs"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ethanol",
          "context": "For alcohol"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Substance Abuse or Dependence on Alcohol",
          "context": "met the criteria for Substance Abuse or Dependence on Alcohol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "nicotine",
          "context": "For nicotine"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Nicotiana",
          "context": "users of a tobacco product"
        }
      ]
    },
    {
      "chunk_id": "ddf164a4072cb74780764f32be06eac7",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "opioids",
          "context": "opioids and alcohol have been shown to be directly self-administered"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alcohol",
          "context": "opioids and alcohol have been shown to be directly self-administered"
        },
        {
          "entity_type": "Effect",
          "entity_name": "self-administered",
          "context": "have been shown to be directly self-administered into the VTA"
        },
        {
          "entity_type": "Effect",
          "entity_name": "place conditioning",
          "context": "intracranial place conditioning"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Opioids",
          "context": "Opioids also produce conditioned place preference"
        },
        {
          "entity_type": "Effect",
          "entity_name": "conditioned place preference",
          "context": "produce conditioned place preference when injected into the VTA"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Opioids",
          "context": "Opioids, phencyclidine, and psychostimulants are directly self-administered"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phencyclidine",
          "context": "phencyclidine, and psychostimulants are directly self-administered"
        },
        {
          "entity_type": "Compound",
          "entity_name": "psychostimulants",
          "context": "psychostimulants are directly self-administered into the nucleus accumbens"
        },
        {
          "entity_type": "Effect",
          "entity_name": "self-administered",
          "context": "are directly self-administered into the nucleus accumbens"
        },
        {
          "entity_type": "Compound",
          "entity_name": "psychostimulants",
          "context": "psychostimulants produce a conditioned place preference"
        },
        {
          "entity_type": "Effect",
          "entity_name": "conditioned place preference",
          "context": "produce a conditioned place preference when injected into the nucleus accumbens"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Cocaine",
          "context": "Cocaine and phencyclidine are directly self-administered"
        },
        {
          "entity_type": "Compound",
          "entity_name": "phencyclidine",
          "context": "Cocaine and phencyclidine are directly self-administered"
        },
        {
          "entity_type": "Effect",
          "entity_name": "self-administered",
          "context": "are directly self-administered into the frontal cortex"
        },
        {
          "entity_type": "Effect",
          "entity_name": "activated",
          "context": "system is activated by acute administration"
        },
        {
          "entity_type": "Compound",
          "entity_name": "opioids",
          "context": "administration of opioids, ethanol, nicotine, and \\Delta^9-THC"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ethanol",
          "context": "administration of opioids, ethanol, nicotine, and \\Delta^9-THC"
        },
        {
          "entity_type": "Compound",
          "entity_name": "nicotine",
          "context": "administration of opioids, ethanol, nicotine, and \\Delta^9-THC"
        },
        {
          "entity_type": "Compound",
          "entity_name": "\\Delta^9-THC",
          "context": "administration of opioids, ethanol, nicotine, and \\Delta^9-THC"
        }
      ]
    },
    {
      "chunk_id": "117bbf153ab077ce99f6a7a757199870",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "nicotine",
          "context": "Intravenous nicotine self-administration"
        },
        {
          "entity_type": "Effect",
          "entity_name": "self-administration",
          "context": "nicotine self-administration"
        },
        {
          "entity_type": "Effect",
          "entity_name": "blocked",
          "context": "self-administration is blocked"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "mesocorticolimbic dopamine system"
        },
        {
          "entity_type": "Effect",
          "entity_name": "receptor activation",
          "context": "nicotinic receptor activation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "release",
          "context": "activation of release of dopamine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "release of dopamine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "nicotine",
          "context": "nicotine reward"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reward",
          "context": "nicotine reward"
        },
        {
          "entity_type": "Effect",
          "entity_name": "conditioned place preference",
          "context": "measured by conditioned place preference"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "mesocorticolimbic dopamine system"
        }
      ]
    },
    {
      "chunk_id": "4d4d9342ba49face27f929dfd0ee10b9",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "dopamine receptor blockade"
        },
        {
          "entity_type": "Effect",
          "entity_name": "receptor blockade",
          "context": "dopamine receptor blockade"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "decreased cocaine-seeking"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cocaine-seeking",
          "context": "decreased cocaine-seeking"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reinforcing effects",
          "context": "acute reinforcing effects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "psychostimulant drugs",
          "context": "psychostimulant drugs"
        },
        {
          "entity_type": "Disease",
          "entity_name": "compulsive use",
          "context": "transition to compulsive use"
        }
      ]
    },
    {
      "chunk_id": "28bf4fd61eb48af2e0d2ed048ca2bbed",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "drug reward",
          "context": "neurobiological circuit for drug reward"
        },
        {
          "entity_type": "Compound",
          "entity_name": "monoamine",
          "context": "ascending monoamine pathways"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "mesocorticolimbic dopamine system"
        }
      ]
    },
    {
      "chunk_id": "2b1057e2521dd157f95490262a3d7de8",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "dopamine release"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "for cocaine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "amphetamine",
          "context": "amphetamine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "nicotine",
          "context": "and nicotine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "opioid peptide",
          "context": "opioid peptide receptor activation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "dopamine activation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "opiates",
          "context": "for opiates"
        },
        {
          "entity_type": "Compound",
          "entity_name": "GABA_A",
          "context": "GABA_A systems"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alcohol",
          "context": "for alcohol"
        }
      ]
    },
    {
      "chunk_id": "1768e52b86f3b9f09db381276afdfc4d",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "reinforcing effects",
          "context": "acute reinforcing effects of drugs"
        }
      ]
    },
    {
      "chunk_id": "8e1bf91c9f68871cec9558b8b5ebe0ad",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "dynorphin",
          "context": "dynorphin is increased"
        },
        {
          "entity_type": "Effect",
          "entity_name": "aversive effects",
          "context": "aversive effects of drug withdrawal"
        },
        {
          "entity_type": "Effect",
          "entity_name": "drug withdrawal",
          "context": "aversive effects of drug withdrawal"
        },
        {
          "entity_type": "Effect",
          "entity_name": "dopaminergic activation",
          "context": "dopaminergic activation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "decrease dopaminergic function",
          "context": "decrease dopaminergic function"
        },
        {
          "entity_type": "Compound",
          "entity_name": "\\kappa-Opioid agonists",
          "context": "\\kappa-Opioid agonists are aversive"
        },
        {
          "entity_type": "Effect",
          "entity_name": "aversive",
          "context": "\\kappa-Opioid agonists are aversive"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "cocaine, opioid, and ethanol withdrawal"
        },
        {
          "entity_type": "Compound",
          "entity_name": "opioid",
          "context": "cocaine, opioid, and ethanol withdrawal"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ethanol",
          "context": "cocaine, opioid, and ethanol withdrawal"
        },
        {
          "entity_type": "Effect",
          "entity_name": "withdrawal",
          "context": "ethanol withdrawal is associated"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dynorphin",
          "context": "increased dynorphin"
        },
        {
          "entity_type": "Compound",
          "entity_name": "salvidorin A",
          "context": "salvidorin A, which is a \\kappa-agonist"
        },
        {
          "entity_type": "Compound",
          "entity_name": "\\kappa-agonist",
          "context": "which is a \\kappa-agonist"
        },
        {
          "entity_type": "Effect",
          "entity_name": "hallucinogenic effects",
          "context": "hallucinogenic effects"
        },
        {
          "entity_type": "Effect",
          "entity_name": "pleasurable properties",
          "context": "pleasurable properties"
        }
      ]
    },
    {
      "chunk_id": "2c9ff6e393e262124ccb638bae826e3b",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Glutamate",
          "context": "a glutamatergic pathway"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Dopamine",
          "context": "the dopamine projection"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Gamma-aminobutyric acid",
          "context": "the GABA projection"
        }
      ]
    },
    {
      "chunk_id": "da862fd2f30135e181d86a3648c72e88",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Corticotropin-releasing factor",
          "context": "activation of both CRF and norepinephrine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "norepinephrine",
          "context": "activation of both CRF and norepinephrine"
        },
        {
          "entity_type": "Effect",
          "entity_name": "stress-induced reinstatement of drug-related responding",
          "context": "stress-induced reinstatement of drug-related responding in animal models"
        },
        {
          "entity_type": "Effect",
          "entity_name": "drug-related responding",
          "context": "stress-induced reinstatement of drug-related responding"
        },
        {
          "entity_type": "Disease",
          "entity_name": "Protracted abstinence",
          "context": "Protracted abstinence, largely described in alcohol dependence models"
        },
        {
          "entity_type": "Disease",
          "entity_name": "alcohol dependence",
          "context": "largely described in alcohol dependence models"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glutamate",
          "context": "overactive glutamatergic and CRF systems"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Corticotropin-releasing factor",
          "context": "overactive glutamatergic and CRF systems"
        },
        {
          "entity_type": "Effect",
          "entity_name": "overactive glutamatergic and Corticotropin-releasing factor systems",
          "context": "appears to involve overactive glutamatergic and CRF systems"
        }
      ]
    },
    {
      "chunk_id": "1500a56b07081743dcb71ac8cde2b5de",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "cocaine addiction",
          "context": "Human subjects with cocaine addiction show impaired performance"
        },
        {
          "entity_type": "Effect",
          "entity_name": "impaired performance",
          "context": "show impaired performance in tasks involving attention"
        },
        {
          "entity_type": "Effect",
          "entity_name": "attention",
          "context": "tasks involving attention, cognitive flexibility"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cognitive flexibility",
          "context": "attention, cognitive flexibility, and delayed reward discounting"
        },
        {
          "entity_type": "Effect",
          "entity_name": "delayed reward discounting",
          "context": "cognitive flexibility, and delayed reward discounting"
        },
        {
          "entity_type": "Effect",
          "entity_name": "spatial memory impairments",
          "context": "spatial, verbal, and recognition memory impairments"
        },
        {
          "entity_type": "Effect",
          "entity_name": "verbal memory impairments",
          "context": "verbal, and recognition memory impairments"
        },
        {
          "entity_type": "Effect",
          "entity_name": "recognition memory impairments",
          "context": "recognition memory impairments that are mediated by the hippocampus"
        },
        {
          "entity_type": "Disease",
          "entity_name": "addiction",
          "context": "in addiction using animal models"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "Experimenter-administered cocaine produced impairments in reversal learning"
        },
        {
          "entity_type": "Effect",
          "entity_name": "impairments in reversal learning",
          "context": "cocaine produced impairments in reversal learning"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "access, but not limited access, to cocaine showed deficits"
        },
        {
          "entity_type": "Effect",
          "entity_name": "deficits in working memory",
          "context": "cocaine showed deficits in working memory"
        },
        {
          "entity_type": "Effect",
          "entity_name": "sustained attention task",
          "context": "sustained attention task (a prefrontal-cortex-dependent task)"
        },
        {
          "entity_type": "Effect",
          "entity_name": "object recognition task",
          "context": "an object recognition task (a hippocampus-dependent task)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine D2 receptor mRNA",
          "context": "decrease in dopamine D2 receptor mRNA in the medial and orbital prefrontal cortices"
        },
        {
          "entity_type": "Effect",
          "entity_name": "decrease in dopamine D2 receptor mRNA",
          "context": "associated with a significant decrease in dopamine D2 receptor mRNA"
        },
        {
          "entity_type": "Disease",
          "entity_name": "cocaine addiction",
          "context": "associated with human cocaine addiction"
        }
      ]
    },
    {
      "chunk_id": "2cc5e978fc99bb1c86c08df35cdff211",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "brain pharmacokinetics of cocaine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "methamphetamine",
          "context": "cocaine and of methamphetamine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "cocaine is taken every 30\u201360 min"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "every 30\u201360 min",
          "context": "taken every 30\u201360 min"
        },
        {
          "entity_type": "Compound",
          "entity_name": "methamphetamine",
          "context": "methamphetamine is taken every couple of hours"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "every couple of hours",
          "context": "taken every couple of hours"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alcohol",
          "context": "exception of alcohol"
        },
        {
          "entity_type": "Effect",
          "entity_name": "stimulant",
          "context": "stimulant drugs such as methylphenidate"
        },
        {
          "entity_type": "Compound",
          "entity_name": "methylphenidate",
          "context": "drugs such as methylphenidate"
        },
        {
          "entity_type": "Compound",
          "entity_name": "amphetamine",
          "context": "methylphenidate or amphetamine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "increase dopamine"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reinforcing",
          "context": "not typically perceived as reinforcing"
        }
      ]
    },
    {
      "chunk_id": "5306ee2ba9d1c0b59cc704e1a734a3e2",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "rewarding responses",
          "context": "influences the rewarding responses to drugs"
        },
        {
          "entity_type": "Effect",
          "entity_name": "brain activation response",
          "context": "regional brain activation response of the brain"
        },
        {
          "entity_type": "Effect",
          "entity_name": "rewarding effects",
          "context": "dependency of the drug's rewarding effects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glutamate",
          "context": "neurotransmitters such as glutamate"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "reactivity of dopamine cells and dopamine release"
        },
        {
          "entity_type": "Effect",
          "entity_name": "dopamine release",
          "context": "dopamine release in the nucleus accumbens"
        }
      ]
    },
    {
      "chunk_id": "2af7262737a569dfca2e056ceca8e199",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "drug intoxication",
          "context": "stage of drug intoxication"
        },
        {
          "entity_type": "Disease",
          "entity_name": "abuse",
          "context": "frequency of its abuse"
        },
        {
          "entity_type": "Compound",
          "entity_name": "opiates",
          "context": "such as opiates"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alcohol",
          "context": "opiates, alcohol"
        },
        {
          "entity_type": "Compound",
          "entity_name": "sedative hypnotics",
          "context": "and sedative hypnotics"
        },
        {
          "entity_type": "Effect",
          "entity_name": "drug discontinuation",
          "context": "drug discontinuation in chronic drug users"
        },
        {
          "entity_type": "Disease",
          "entity_name": "chronic drug users",
          "context": "in chronic drug users"
        },
        {
          "entity_type": "Disease",
          "entity_name": "physical withdrawal syndrome",
          "context": "acute physical withdrawal syndrome"
        },
        {
          "entity_type": "Effect",
          "entity_name": "fatal",
          "context": "can sometimes be fatal"
        },
        {
          "entity_type": "Disease",
          "entity_name": "motivational withdrawal syndrome",
          "context": "a motivational withdrawal syndrome"
        },
        {
          "entity_type": "Disease",
          "entity_name": "dysphoria",
          "context": "characterized by dysphoria"
        },
        {
          "entity_type": "Disease",
          "entity_name": "irritability",
          "context": "dysphoria, irritability"
        }
      ]
    },
    {
      "chunk_id": "d23e3a683994b0e3cad1690e71c57e2d",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "distress",
          "context": "distress, and sleep disturbances"
        },
        {
          "entity_type": "Disease",
          "entity_name": "sleep disturbances",
          "context": "sleep disturbances that persist"
        },
        {
          "entity_type": "Disease",
          "entity_name": "withdrawal",
          "context": "protracted withdrawal"
        },
        {
          "entity_type": "Disease",
          "entity_name": "withdrawal",
          "context": "acute withdrawal"
        },
        {
          "entity_type": "Disease",
          "entity_name": "withdrawal",
          "context": "motivational withdrawal"
        },
        {
          "entity_type": "Disease",
          "entity_name": "relapse",
          "context": "contribute to relapse"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "changes in dopamine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "heroin",
          "context": "during heroin withdrawal"
        },
        {
          "entity_type": "Disease",
          "entity_name": "withdrawal",
          "context": "heroin withdrawal"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "dopamine decreases"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "striatal dopamine"
        },
        {
          "entity_type": "Disease",
          "entity_name": "heroin addiction",
          "context": "in heroin abusers"
        },
        {
          "entity_type": "Compound",
          "entity_name": "heroin",
          "context": "in heroin abusers"
        }
      ]
    },
    {
      "chunk_id": "23dd0d8e3bcac33036eef16a9e444644",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "addiction",
          "context": "development of addiction"
        },
        {
          "entity_type": "Disease",
          "entity_name": "addiction",
          "context": "stages of the addiction cycle"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "mesolimbic dopamine system"
        }
      ]
    },
    {
      "chunk_id": "2e3c1abc58ff11b6fc7fdc770cc4870d",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Dopamine",
          "context": "Mesolimbic Dopamine System"
        }
      ]
    },
    {
      "chunk_id": "19b00f35404621b65e932f8c9480849e",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "Compulsivity \u2013 loss of control",
          "context": "'Compulsivity \u2013 loss of control'"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Dopamine",
          "context": "'Mesolimbic DA'"
        }
      ]
    },
    {
      "chunk_id": "6303d7810e975fc83e2c88f9d9b4f2eb",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "behavioral sensitization",
          "context": "showed behavioral sensitization"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "cocaine-sensitized mice"
        },
        {
          "entity_type": "Effect",
          "entity_name": "enhancement of LTP",
          "context": "showed an enhancement of LTP"
        },
        {
          "entity_type": "Effect",
          "entity_name": "glutamatergic activity",
          "context": "increased activity of glutamatergic activity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "withdrawal",
          "context": "during withdrawal"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glutamate-1 receptors (GluR1)",
          "context": "ratio of glutamate-1 receptors (GluR1)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "last injection of cocaine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "AMPA receptors",
          "context": "redistribution of AMPA receptors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "GluR2",
          "context": "lacking GluR2"
        },
        {
          "entity_type": "Compound",
          "entity_name": "AMPA receptors",
          "context": "cell-surface AMPA receptors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine D_1 receptors",
          "context": "activation of dopamine D_1 receptors"
        },
        {
          "entity_type": "Compound",
          "entity_name": "protein kinase A",
          "context": "subsequent protein kinase A signaling"
        },
        {
          "entity_type": "Compound",
          "entity_name": "GluR1",
          "context": "overexpression of GluR1"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "extinction of cocaine-seeking responses"
        },
        {
          "entity_type": "Effect",
          "entity_name": "extinction of cocaine-seeking responses",
          "context": "facilitated extinction of cocaine-seeking responses"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increased brain stimulation reward thresholds",
          "context": "increased brain stimulation reward thresholds"
        },
        {
          "entity_type": "Effect",
          "entity_name": "decreased reward",
          "context": "reflecting decreased reward"
        },
        {
          "entity_type": "Effect",
          "entity_name": "decreased motivated behavior",
          "context": "decreased motivated behavior"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "reexposure to cocaine"
        },
        {
          "entity_type": "Effect",
          "entity_name": "withdrawal",
          "context": "during extended withdrawal"
        },
        {
          "entity_type": "Effect",
          "entity_name": "synaptic depression",
          "context": "produced synaptic depression"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glutamate",
          "context": "enhanced glutamate release"
        },
        {
          "entity_type": "Compound",
          "entity_name": "AMPA receptor",
          "context": "increase in AMPA receptor expression"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "observed with cocaine"
        },
        {
          "entity_type": "Compound",
          "entity_name": "amphetamine",
          "context": "in amphetamine-sensitized rats"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glutamate",
          "context": "effects of glutamate projections"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cocaine withdrawal",
          "context": "during cocaine vs amphetamine withdrawal"
        },
        {
          "entity_type": "Effect",
          "entity_name": "amphetamine withdrawal",
          "context": "cocaine vs amphetamine withdrawal"
        }
      ]
    },
    {
      "chunk_id": "5e5a398ca7c46fdd910fcb172c7e4d67",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "compulsive cocaine use"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "increased dopamine release"
        },
        {
          "entity_type": "Effect",
          "entity_name": "increased dopamine release",
          "context": "increased dopamine release in the dorsal striatum"
        },
        {
          "entity_type": "Disease",
          "entity_name": "compulsive cocaine use",
          "context": "habitual compulsive cocaine use"
        },
        {
          "entity_type": "Disease",
          "entity_name": "drug addiction",
          "context": "drug addiction represents changes"
        }
      ]
    },
    {
      "chunk_id": "80d9ab58b63ff5ef34be7453932666a0",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "striatal slow dopamine increases"
        },
        {
          "entity_type": "Compound",
          "entity_name": "methylphenidate",
          "context": "oral methylphenidate"
        },
        {
          "entity_type": "Effect",
          "entity_name": "craving",
          "context": "do not elicit craving"
        },
        {
          "entity_type": "Disease",
          "entity_name": "cocaine abusers",
          "context": "in cocaine abusers"
        },
        {
          "entity_type": "Effect",
          "entity_name": "craving",
          "context": "the craving results from"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "fast dopamine increases"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "phasic dopamine firing"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "slow dopamine increases"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "tonic dopamine firing"
        },
        {
          "entity_type": "Compound",
          "entity_name": "methylphenidate",
          "context": "oral methylphenidate"
        },
        {
          "entity_type": "Compound",
          "entity_name": "methylphenidate",
          "context": "intravenous administration of methylphenidate"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "fast dopamine increases"
        },
        {
          "entity_type": "Effect",
          "entity_name": "craving",
          "context": "induces intense craving"
        }
      ]
    },
    {
      "chunk_id": "df0ae8afc36f1751494dcf9eb5d4cf47",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "drug-addicted",
          "context": "in drug-addicted subjects"
        },
        {
          "entity_type": "Effect",
          "entity_name": "salience attribution",
          "context": "implicated in salience attribution"
        },
        {
          "entity_type": "Effect",
          "entity_name": "motivation",
          "context": "salience attribution and motivation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "compulsivity",
          "context": "results in compulsivity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "inhibitory control",
          "context": "implicated in inhibitory control"
        },
        {
          "entity_type": "Effect",
          "entity_name": "conflict resolution",
          "context": "inhibitory control and conflict resolution"
        },
        {
          "entity_type": "Effect",
          "entity_name": "impulsivity",
          "context": "results in impulsivity"
        },
        {
          "entity_type": "Disease",
          "entity_name": "cocaine-addicted",
          "context": "in cocaine-addicted subjects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "methylphenidate",
          "context": "administration of methylphenidate"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cocaine",
          "context": "similar to those of cocaine"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cocaine craving",
          "context": "associated with cocaine craving"
        },
        {
          "entity_type": "Disease",
          "entity_name": "marijuana-addicted",
          "context": "in marijuana-addicted subjects"
        },
        {
          "entity_type": "Compound",
          "entity_name": "\\Delta^9-THC",
          "context": "administration of \\Delta^9-THC"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reward",
          "context": "predict reward"
        },
        {
          "entity_type": "Effect",
          "entity_name": "craving",
          "context": "trigger craving"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "regulate dopamine cell firing and release"
        },
        {
          "entity_type": "Effect",
          "entity_name": "incentive motivational values",
          "context": "enhanced incentive motivational values"
        },
        {
          "entity_type": "Disease",
          "entity_name": "addicted individuals",
          "context": "drugs in addicted individuals"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "dopamine increases"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glutamatergic",
          "context": "glutamatergic afferents"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "increases in dopamine"
        },
        {
          "entity_type": "Effect",
          "entity_name": "compulsive drug consumption",
          "context": "contribute to the compulsive drug consumption"
        },
        {
          "entity_type": "Effect",
          "entity_name": "drug bingeing",
          "context": "characterizes drug bingeing"
        },
        {
          "entity_type": "Disease",
          "entity_name": "addicted individuals",
          "context": "drug bingeing in addicted individuals"
        }
      ]
    },
    {
      "chunk_id": "568526dedd0adac49f1f2e1d2b475833",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "striatal dopamine activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "dopamine cell activity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "modulating dopamine increases"
        },
        {
          "entity_type": "Disease",
          "entity_name": "addiction",
          "context": "in addicted individuals"
        }
      ]
    },
    {
      "chunk_id": "cbbebfb84757c14da4c38cb13a772473",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "dopamine",
          "context": "concomitant dopamine and glutamate neurotransmission"
        },
        {
          "entity_type": "Compound",
          "entity_name": "glutamate",
          "context": "concomitant dopamine and glutamate neurotransmission"
        },
        {
          "entity_type": "Disease",
          "entity_name": "craving",
          "context": "involved in cue/context-dependent craving"
        },
        {
          "entity_type": "Disease",
          "entity_name": "addiction",
          "context": "component of addiction"
        }
      ]
    }
  ],
  "total_entities": 253,
  "extraction_date": "2026-02-01T08:55:57.498679+00:00"
}